First-line liposomal irinotecan+5 fluorouracil/leucovorin plus oxaliplatin in patients with pancreatic ductal adenocarcinoma: Long-term follow-up results from a phase 1/2 study

被引：2
|
作者：
Wainberg, Z. [1 ]
Bekaii-Saab, T. [2 ]
Boland, P. [3 ]
Dayyani, F. [4 ]
Macarulla, T. [5 ,6 ]
Mody, K. [5 ,6 ,7 ]
Belanger, B. [8 ]
Maxwell, F. [9 ]
Moore, Y. [8 ]
Thiagalingam, A. [8 ]
Wang, T. [8 ]
Zhang, B. [8 ]
Dean, A. [10 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Mayo Clin Phoenix, Phoenix, AZ USA
[3] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[4] Univ Calif Irvine, Med Ctr, Orange, CA 92668 USA
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Vall dHebron Inst Oncol, Barcelona, Spain
[7] Mayo Clin, Jacksonville, FL 32224 USA
[8] Ipsen, Cambridge, MA USA
[9] Ipsen, Abingdon, Oxon, England
[10] St John God Subiaco Hosp, Dept Oncol, Subiaco, WA, Australia
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA-1
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [41] Phase II study of irinotecan plus leucovorin and bolus 5 fluorouracil as first or second line chemotherapy in patients with advanced gastric or esophageal-gastric junction adenocarcinoma
    Gerolymos, M.
    Koutras, A.
    Kontogeorgou, E.
    Iconomou, G.
    Vourli, G.
    Tsiata, E.
    Makatsoris, T.
    Chrysanthopoulos, C.
    Kalofonos, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids
    Brokx, Hes A. P.
    Paul, Marinus A.
    Postmus, Pieter E.
    Sutedja, Thomas G.
    THORAX, 2015, 70 (05) : 468 - 472
  • [43] Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Lordick, F.
    Luber, B.
    Lorenzen, S.
    Hegewisch-Becker, S.
    Folprecht, G.
    Woell, E.
    Decker, T.
    Endlicher, E.
    Roethling, N.
    Schuster, T.
    Keller, G.
    Fend, F.
    Peschel, C.
    BRITISH JOURNAL OF CANCER, 2010, 102 (03) : 500 - 505
  • [44] KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy
    Kullmann, F.
    Hartmann, A.
    Stoehr, R.
    Messmann, H.
    Dollinger, M. M.
    Trojan, J.
    Fuchs, M.
    Hollerbach, S.
    Harder, J.
    Troppmann, M.
    Kutscheidt, A.
    Endlicher, E.
    ONCOLOGY, 2011, 81 (01) : 3 - 8
  • [45] Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    F Lordick
    B Luber
    S Lorenzen
    S Hegewisch-Becker
    G Folprecht
    E Wöll
    T Decker
    E Endlicher
    N Röthling
    T Schuster
    G Keller
    F Fend
    C Peschel
    British Journal of Cancer, 2010, 102 : 500 - 505
  • [46] A phase 1/2, open -label, dose -expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer
    Wainberg, Z.
    Boland, P.
    Lieu, C.
    Dayyani, F.
    Macarulla, T.
    Zhang, B.
    Belanger, B.
    Moore, Y.
    Wang, T.
    Maxwell, F.
    Dean, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Long-Term Follow-Up of De Novo Chronic Phase Chronic Myelogenous Leukemia Patients on Imatinib First-Line
    Alcazer, Vincent
    Sujobert, Pierre
    Dulucq, Stephanie
    Morisset, Stephane
    Sobh, Mohamad
    Mahon, Francois-Xavier
    Etienne, Gabriel
    Nicolini, Franck-Emmanuel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S306 - S306
  • [48] Long-term survival in patients with pancreatic cancer (PAC) treated with liposomal irinotecan in combination with 5-fluorouracil and leucovorin (nal-IRI+5-FU/LV)
    Prager, G.
    Potthoff, K.
    Yoo, C.
    Lonardi, S.
    Hedouin-Biville, F.
    Macarulla, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S248 - S249
  • [49] First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center
    Andereggen, L.
    Frey, J.
    Andres, R. H.
    Luedi, M. M.
    El-Koussy, M.
    Widmer, H. R.
    Beck, J.
    Mariani, L.
    Seiler, R. W.
    Christ, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (12) : 2621 - 2633
  • [50] First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center
    L. Andereggen
    J. Frey
    R. H. Andres
    M. M. Luedi
    M. El-Koussy
    H. R. Widmer
    J. Beck
    L. Mariani
    R. W. Seiler
    E. Christ
    Journal of Endocrinological Investigation, 2021, 44 : 2621 - 2633
12345